Pharmaceutical company BioNTech said on Monday that it wants to use the mRNA technology behind its coronavirus vaccine to target malaria.
Vaccine Maker BioNTech To Use mRNA tech To Target Malaria

€5,000,000
14:34 - 06 Αυγουστου 2025
Από €127,000
14:36 - 06 Αυγουστου 2025
€395,000
14:39 - 06 Αυγουστου 2025
€310,000
14:39 - 06 Αυγουστου 2025